OCWP
GMAB icon

Owl Creek Wealth Partners’s Genmab GMAB Stock Holding History

Owl Creek Wealth Partners’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.1K Sell
842
-40
-5% -$1.06K 0.01% 597
2026
Q1 		$23.7K Buy
+882
New +$26.4K 0.01% 524

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Owl Creek Wealth Partners's GMAB Position: Q2 2026 in Review

Owl Creek Wealth Partners reduced its Genmab (GMAB) stake by 4.5% in Q2 2026, selling an estimated $1.06K and leaving 842 shares worth $23.1K. The position accounts for 0.01% of the portfolio, ranked #597.

Owl Creek Wealth Partners first reported a position in GMAB in Q1 2026 and has held it in 2 quarters since. The position peaked at $23.7K in Q1 2026. 290 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Owl Creek Wealth Partners held 842 shares of Genmab worth $23.1K as of Q2 2026.
  • Owl Creek Wealth Partners sold 40 Genmab shares in Q2 2026, an estimated $1.06K.
  • Genmab made up 0.01% of Owl Creek Wealth Partners's portfolio in Q2 2026, its #597 holding.
  • Owl Creek Wealth Partners first reported a position in Genmab in Q1 2026 and has held it in 2 quarters since.
  • Owl Creek Wealth Partners's Genmab position peaked at $23.7K in Q1 2026.
  • 290 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Owl Creek Wealth Partners's 13F filing for Q2 2026, filed 20 Jul 2026.